IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 336 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $209,654 | -2.5% | 4,622 | -5.0% | 0.12% | -22.0% |
| Q3 2022 | $215,000 | +5.9% | 4,866 | -11.3% | 0.16% | +23.3% |
| Q1 2022 | $203,000 | -12.1% | 5,489 | -20.3% | 0.13% | -22.3% |
| Q3 2021 | $231,000 | -16.6% | 6,888 | -0.7% | 0.17% | -16.2% |
| Q2 2021 | $277,000 | -12.1% | 6,936 | -1.0% | 0.20% | -18.9% |
| Q1 2021 | $315,000 | -20.7% | 7,005 | -0.2% | 0.24% | -26.9% |
| Q4 2020 | $397,000 | – | 7,021 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,136 | $133,749 | 7.12% |
| Bellevue Group AG | 9,743,900 | $368,027,103 | 4.88% |
| M28 Capital Management LP | 126,300 | $4,770,351 | 4.55% |
| Sicart Associates LLC | 246,258 | $9,301,165 | 3.28% |
| Camber Capital Management LP | 1,925,000 | $72,707 | 2.49% |
| Privium Fund Management B.V. | 148,807 | $5,557,941 | 2.11% |
| Deep Track Capital, LP | 1,205,773 | $45,542,046 | 1.91% |
| BVF INC/IL | 1,121,809 | $42,370,726 | 1.79% |
| Orbimed Advisors | 1,993,600 | $75,298,272 | 1.44% |
| Parkman Healthcare Partners LLC | 141,115 | $5,329,914 | 1.42% |